Upper Respiratory Infections: Clinical Trials

2 trials for Upper Respiratory Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Upper Respiratory Infections: new trials by email Literature Review of Upper Respiratory Infections trials Research Report on Upper Respiratory Infections

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI
IFF flavor 316 282, Paracetamol, Pseudoephedrine - Upper Respiratory Infections
Phase 3CompletedNovartis562012-05-012013-08-07
Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)
IFF flavor 316 282, Paracetamol , Phenylephrine, Guaifenesin - Upper Respiratory Infections
Phase 3CompletedNovartis512012-03-012013-11-11

Narrower conditions

Respiratory Tract Infections (2)

Broader conditions

Infections (2)  ·  Respiratory Tract Diseases (2)

Interventions

Acetaminophen (2)  ·  Guaifenesin (1)  ·  Phenylephrine (1)  ·  Pseudoephedrine (1)

Sponsors

Novartis (2)

Countries

Canada (2)